Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
ATB: Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Reltecimod as Compared to Placebo in Addition to Standard of Care in Patients
Sponsored by Atox Bio Ltd. (Israel)
$163.3K Funding
1 People
External
Related Topics
clinical trials,
immunotherapy,
patient safety,
medical treatment,
infection control
People
Lynn Gries
Principal Investigator (PI)
Surgery
﹒Associate Professor
